Feverfew (Tanacetum parthenium) contains parthenolides, which inhibit platelet aggregation and reduce inflammatory mediators by suppressing NF-κB activation. Its primary mechanism in cluster headache treatment involves modulating serotonin receptor activity and reducing neurogenic inflammation, potentially decreasing the frequency and intensity of headache episodes through its anti-inflammatory and vasodilatory properties.